Analystreport

Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock.

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com